Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission

British Journal of Haematology

Volumn 161, Issue 1, 2013, Pages 27-42

  Hochberg, Jessica ^a   Khaled, Samer ^b   Forman, Stephen J ^b   Cairo, Mitchell S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b City of Hope ^*  (United States)

Author keywords

Acute lymphoblastic leukaemia; Allogeneic stem cell transplantation; Children; CR1; Young adults

Indexed keywords

BUSULFAN; CLOFARABINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IMATINIB;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER GROWTH; CANCER REGRESSION; CELL THERAPY; CHILD; CONSOLIDATION CHEMOTHERAPY; CYTOGENETICS; DRUG MEGADOSE; EVENT FREE SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNOPHENOTYPING; IMMUNOTHERAPY; INFANT; LEUKOCYTE COUNT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MOLECULAR GENETICS; PHARMACOGENOMICS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASM, RESIDUAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; PROTEIN KINASE INHIBITORS; REMISSION INDUCTION; RISK FACTORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875053482     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12239     Document Type: Review

References (101)

1. Appelbaum, F.R. (1997) Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL). Leukemia, 11(Suppl. 4), S15-S17.
2. Arico, M., Valsecchi, M.G., Camitta, B., Schrappe, M., Chessells, J., Baruchel, A., Gaynon, P., Silverman, L., Janka-Schaub, G., Kamps, W., Pui, C.H. & Masera, G. (2000) Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. New England Journal of Medicine, 342, 998-1006.
3. Arico, M., Schrappe, M., Hunger, S.P., Carroll, W.L., Conter, V., Galimberti, S., Manabe, A., Saha, V., Baruchel, A., Vettenranta, K., Horibe, K., Benoit, Y., Pieters, R., Escherich, G., Silverman, L.B., Pui, C.H. & Valsecchi, M.G. (2010) Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. Journal of Clinical Oncology, 28, 4755-4761.
4. Arnold, R., Massenkeil, G., Bornhauser, M., Ehninger, G., Beelen, D.W., Fauser, A.A., Hegenbart, U., Hertenstein, B., Ho, A.D., Knauf, W., Kolb, H.J., Kolbe, K., Sayer, H.G., Schwerdtfeger, R., Wandt, H. & Hoelzer, D. (2002) Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease. Leukemia, 16, 2423-2428.
5. Atsuta, Y., Suzuki, R., Nagamura-Inoue, T., Taniguchi, S., Takahashi, S., Kai, S., Sakamaki, H., Kouzai, Y., Kasai, M., Fukuda, T., Azuma, H., Takanashi, M., Okamoto, S., Tsuchida, M., Kawa, K., Morishima, Y., Kodera, Y. & Kato, S. (2009) Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood, 113, 1631-1638.
6. Bacigalupo, A., Oneto, R., Lamparelli, T., Gualandi, F., Bregante, S., Raiola, A.M., Di Grazia, C., Dominietto, A., Romagnani, C., Bruno, B., Van Lint, M.T. & Frassoni, F. (2001) Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG). Bone Marrow Transplantation, 28, 1093-1096.
7. Baker, K.S., Ness, K.K., Weisdorf, D., Francisco, L., Sun, C.L., Forman, S. & Bhatia, S. (2010) Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia, 24, 2039-2047.
8. Balduzzi, A., Valsecchi, M.G., Uderzo, C., De Lorenzo, P., Klingebiel, T., Peters, C., Stary, J., Felice, M.S., Magyarosy, E., Conter, V., Reiter, A., Messina, C., Gadner, H. & Schrappe, M. (2005) Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet, 366, 635-642.
9. Bassan, R., Spinelli, O., Oldani, E., Intermesoli, T., Tosi, M., Peruta, B., Rossi, G., Borlenghi, E., Pogliani, E.M., Terruzzi, E., Fabris, P., Cassibba, V., Lambertenghi-Deliliers, G., Cortelezzi, A., Bosi, A., Gianfaldoni, G., Ciceri, F., Bernardi, M., Gallamini, A., Mattei, D., Di Bona, E., Romani, C., Scattolin, A.M., Barbui, T. & Rambaldi, A. (2009) Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL). Blood, 113, 4153-4162.
10. Basso, G., Veltroni, M., Valsecchi, M.G., Dworzak, M.N., Ratei, R., Silvestri, D., Benetello, A., Buldini, B., Maglia, O., Masera, G., Conter, V., Arico, M., Biondi, A. & Gaipa, G. (2009) Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. Journal of Clinical Oncology, 27, 5168-5174.
11. Blume, K.G., Forman, S.J., Snyder, D.S., Nademanee, A.P., O'Donnell, M.R., Fahey, J.L., Krance, R.A., Sniecinski, I.J., Stock, A.D., Findley, D.O., Lipsett, J.A., Schmidt, G.M., Nathwani, M.B., Hill, L.R. & Metter, G.E. (1987a) Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission. Transplantation, 43, 389-392.
12. Blume, K.G., Forman, S.J., O'Donnell, M.R., Doroshow, J.H., Krance, R.A., Nademanee, A.P., Snyder, D.S., Schmidt, G.M., Fahey, J.L. & Metter, G.E. (1987b) Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood, 69, 1015-1020.
13. Blume, K.G., Kopecky, K.J., Henslee-Downey, J.P., Forman, S.J., Stiff, P.J., LeMaistre, C.F. & Appelbaum, F.R. (1993) A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study. Blood, 81, 2187-2193.
14. de Bont, J.M., Holt, B., Dekker, A.W., van der Does-van den Berg, A., Sonneveld, P. & Pieters, R. (2004) Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia, 18, 2032-2035.
15. Bruggemann, M., Raff, T., Flohr, T., Gokbuget, N., Nakao, M., Droese, J., Luschen, S., Pott, C., Ritgen, M., Scheuring, U., Horst, H.A., Thiel, E., Hoelzer, D., Bartram, C.R. & Kneba, M. (2006) Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood, 107, 1116-1123.
16. Bruggemann, M., Schrauder, A., Raff, T., Pfeifer, H., Dworzak, M., Ottmann, O.G., Asnafi, V., Baruchel, A., Bassan, R., Benoit, Y., Biondi, A., Cave, H., Dombret, H., Fielding, A.K., Foa, R., Gokbuget, N., Goldstone, A.H., Goulden, N., Henze, G., Hoelzer, D., Janka-Schaub, G.E., Macintyre, E.A., Pieters, R., Rambaldi, A., Ribera, J.M., Schmiegelow, K., Spinelli, O., Stary, J., von Stackelberg, A., Kneba, M., Schrappe, M. & van Dongen, J.J. (2010) Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia, 24, 521-535.
17. Brüggemann, M., Raff, T. & Kneba, M. (2012) Has MRD monitoring superseded other prognostic factors in adult ALL? Blood, 120, 4470-4481. doi:10.1182/blood-2012-06-379040.
18. Burke, M.J., Cao, Q., Trotz, B., Weigel, B., Kumar, A., Smith, A. & Verneris, M.R. (2009) Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer, 53, 1289-1294.
19. Carpenter, P.A., Snyder, D.S., Flowers, M.E., Sanders, J.E., Gooley, T.A., Martin, P.J., Appelbaum, F.R. & Radich, J.P. (2007) Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia. Blood, 109, 2791-2793.
20. Chao, N.J., Forman, S.J., Schmidt, G.M., Snyder, D.S., Amylon, M.D., Konrad, P.N., Nademanee, A.P., O'Donnell, M.R., Parker, P.M. & Stein, A.S. (1991) Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood, 78, 1923-1927.
21. Chessells, J.M., Bailey, C., Wheeler, K. & Richards, S.M. (1992) Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X. Lancet, 340, 565-568.
22. Cornelissen, J.J., van der Holt, B., Verhoef, G.E., van't Veer, M.B., van Oers, M.H., Schouten, H.C., Ossenkoppele, G., Sonneveld, P., Maertens, J., van Marwijk Kooy, M., Schaafsma, M.R., Wijermans, P.W., Biesma, D.H., Wittebol, S., Voogt, P.J., Baars, J.W., Zachee, P., Verdonck, L.F., Lowenberg, B. & Dekker, A.W. (2009) Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison. Blood, 113, 1375-1382.
23. Coustan-Smith, E., Sancho, J., Hancock, M.L., Boyett, J.M., Behm, F.G., Raimondi, S.C., Sandlund, J.T., Rivera, G.K., Rubnitz, J.E., Ribeiro, R.C., Pui, C.H. & Campana, D. (2000) Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood, 96, 2691-2696.
24. Coustan-Smith, E., Mullighan, C.G., Onciu, M., Behm, F.G., Raimondi, S.C., Pei, D., Cheng, C., Su, X., Rubnitz, J.E., Basso, G., Biondi, A., Pui, C.H., Downing, J.R. & Campana, D. (2009) Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncology, 10, 147-156.
25. Coustan-Smith, E., Song, G., Clark, C., Key, L., Liu, P., Mehrpooya, M., Stow, P., Su, X., Shurtleff, S., Pui, C.H., Downing, J.R. & Campana, D. (2011) New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood, 117, 6267-6276.
26. Dombret, H., Gabert, J., Boiron, J.M., Rigal-Huguet, F., Blaise, D., Thomas, X., Delannoy, A., Buzyn, A., Bilhou-Nabera, C., Cayuela, J.M., Fenaux, P., Bourhis, J.H., Fegueux, N., Charrin, C., Boucheix, C., Lheritier, V., Esperou, H., MacIntyre, E., Vernant, J.P. & Fiere, D. (2002) Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia-results of the prospective multicenter LALA-94 trial. Blood, 100, 2357-2366.
27. Doney, K., Fisher, L.D., Appelbaum, F.R., Buckner, C.D., Storb, R., Singer, J., Fefer, A., Anasetti, C., Beatty, P., Bensinger, W., Hansen, J.A., Martin, P.J. & Sanders, J.E. (1991) Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. Bone Marrow Transplantation, 7, 453-459.
28. Dores, G.M., Devesa, S.S., Curtis, R.E., Linet, M.S. & Morton, L.M. (2012) Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood, 119, 34-43.
29. Duval, M., Klein, J.P., He, W., Cahn, J.Y., Cairo, M., Camitta, B.M., Kamble, R., Copelan, E., de Lima, M., Gupta, V., Keating, A., Lazarus, H.M., Litzow, M.R., Marks, D.I., Maziarz, R.T., Rizzieri, D.A., Schiller, G., Schultz, K.R., Tallman, M.S. & Weisdorf, D. (2010) Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. Journal of Clinical Oncology, 28, 3730-3738.
30. Eapen, M., Rubinstein, P., Zhang, M.J., Camitta, B.M., Stevens, C., Cairo, M.S., Davies, S.M., Doyle, J.J., Kurtzberg, J., Pulsipher, M.A., Ortega, J.J., Scaradavou, A., Horowitz, M.M. & Wagner, J.E. (2006) Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. Journal of Clinical Oncology, 24, 145-151.
31. Fagioli, F., Zecca, M., Rognoni, C., Lanino, E., Balduzzi, A., Berger, M., Messina, C., Favre, C., Rabusin, M., Lo Nigro, L., Masetti, R., Prete, A. & Locatelli, F. (2012) Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Biology of Blood and Marrow Transplantation, 18, 852-860.
32. Fern, L.A. & Whelan, J.S. (2010) Recruitment of adolescents and young adults to cancer clinical trials-international comparisons, barriers, and implications. Seminars in Oncology, 37, e1-e8.
33. Fielding, A.K., Rowe, J.M., Richards, S.M., Buck, G., Moorman, A.V., Durrant, I.J., Marks, D.I., McMillan, A.K., Litzow, M.R., Lazarus, H.M., Foroni, L., Dewald, G., Franklin, I.M., Luger, S.M., Paietta, E., Wiernik, P.H., Tallman, M.S. & Goldstone, A.H. (2009) Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. Blood, 113, 4489-4496.
34. Geyer, M.B., Ricci, A.M., Jacobson, J.S., Majzner, R., Duffy, D., Van de Ven, C., Ayello, J., Bhatia, M., Garvin, J.H. Jr, George, D., Satwani, P., Harrison, L., Morris, E., Semidei-Pomales, M., Schwartz, J., Alobeid, B., Baxter-Lowe, L.A. & Cairo, M.S. (2012) T cell depletion utilizing CD34(+) stem cell selection and CD3(+) addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients. British Journal of Haematology, 157, 205-219.
35. Goldstone, A.H., Richards, S.M., Lazarus, H.M., Tallman, M.S., Buck, G., Fielding, A.K., Burnett, A.K., Chopra, R., Wiernik, P.H., Foroni, L., Paietta, E., Litzow, M.R., Marks, D.I., Durrant, J., McMillan, A., Franklin, I.M., Luger, S., Ciobanu, N. & Rowe, J.M. (2008) In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood, 111, 1827-1833.
36. Hallbook, H., Gustafsson, G., Smedmyr, B., Soderhall, S. & Heyman, M. (2006) Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer, 107, 1551-1561.
37. Harrison, C.J., Moorman, A.V., Broadfield, Z.J., Cheung, K.L., Harris, R.L., Reza Jalali, G., Robinson, H.M., Barber, K.E., Richards, S.M., Mitchell, C.D., Eden, T.O., Hann, I.M., Hill, F.G., Kinsey, S.E., Gibson, B.E., Lilleyman, J., Vora, A., Goldstone, A.H., Franklin, I.M., Durrant, J. & Martineau, M. (2004) Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia. British Journal of Haematology, 125, 552-559.
38. Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., Diedrich, H. & Ruhl, H. (1988) Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood, 71, 123-131.
39. Holowiecki, J., Krawczyk-Kulis, M., Giebel, S., Jagoda, K., Stella-Holowiecka, B., Piatkowska-Jakubas, B., Paluszewska, M., Seferynska, I., Lewandowski, K., Kielbinski, M., Czyz, A., Balana-Nowak, A., Krol, M., Skotnicki, A.B., Jedrzejczak, W.W., Warzocha, K., Lange, A. & Hellmann, A. (2008) Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study. British Journal of Haematology, 142, 227-237.
40. Houtenbos, I., Bracho, F., Davenport, V., Slack, R., van de Ven, C., Suen, Y., Killen, R., Shen, V. & Cairo, M.S. (2001) Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC). Bone Marrow Transplantation, 27, 145-153.
41. Jacobsohn, D.A., Hewlett, B., Morgan, E., Tse, W., Duerst, R.E. & Kletzel, M. (2005) Favorable outcome for infant acute lymphoblastic leukemia after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 11, 999-1005.
42. Jamieson, C.H., Amylon, M.D., Wong, R.M. & Blume, K.G. (2003) Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience. Experimental Hematology, 31, 981-986.
43. Kang, H., Wilson, C.S., Harvey, R.C., Chen, I.M., Murphy, M.H., Atlas, S.R., Bedrick, E.J., Devidas, M., Carroll, A.J., Robinson, B.W., Stam, R.W., Valsecchi, M.G., Pieters, R., Heerema, N.A., Hilden, J.M., Felix, C.A., Reaman, G.H., Camitta, B., Winick, N., Carroll, W.L., Dreyer, Z.E., Hunger, S.P. & Willman, C.L. (2012) Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood, 119, 1872-1881.
44. Kantarjian, H.M., Walters, R.S., Keating, M.J., Smith, T.L., O'Brien, S., Estey, E.H., Huh, Y.O., Spinolo, J., Dicke, K. & Barlogie, B. (1990) Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. Journal of Clinical Oncology, 8, 994-1004.
45. Kiehl, M.G., Kraut, L., Schwerdtfeger, R., Hertenstein, B., Remberger, M., Kroeger, N., Stelljes, M., Bornhaeuser, M., Martin, H., Scheid, C., Ganser, A., Zander, A.R., Kienast, J., Ehninger, G., Hoelzer, D., Diehl, V., Fauser, A.A. & Ringden, O. (2004) Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. Journal of Clinical Oncology, 22, 2816-2825.
46. Kosaka, Y., Koh, K., Kinukawa, N., Wakazono, Y., Isoyama, K., Oda, T., Hayashi, Y., Ohta, S., Moritake, H., Oda, M., Nagatoshi, Y., Kigasawa, H., Ishida, Y., Ohara, A., Hanada, R., Sako, M., Sato, T., Mizutani, S., Horibe, K. & Ishii, E. (2004) Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood, 104, 3527-3534.
47. Kuhnl, A., Gokbuget, N., Stroux, A., Burmeister, T., Neumann, M., Heesch, S., Haferlach, T., Hoelzer, D., Hofmann, W.K., Thiel, E. & Baldus, C.D. (2010) High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia. Blood, 115, 3737-3744.
48. Lang, P., Handgretinger, R., Niethammer, D., Schlegel, P.G., Schumm, M., Greil, J., Bader, P., Engel, C., Scheel-Walter, H., Eyrich, M. & Klingebiel, T. (2003) Transplantation of highly purified CD34 + progenitor cells from unrelated donors in pediatric leukemia. Blood, 101, 1630-1636.
49. Laport, G.G., Alvarnas, J.C., Palmer, J.M., Snyder, D.S., Slovak, M.L., Cherry, A.M., Wong, R.M., Negrin, R.S., Blume, K.G. & Forman, S.J. (2008) Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen. Blood, 112, 903-909.
50. Larson, R.A., Dodge, R.K., Burns, C.P., Lee, E.J., Stone, R.M., Schulman, P., Duggan, D., Davey, F.R., Sobol, R.E. & Frankel, S.R. (1995) A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood, 85, 2025-2037.
51. Laughlin, M.J., Eapen, M., Rubinstein, P., Wagner, J.E., Zhang, M.J., Champlin, R.E., Stevens, C., Barker, J.N., Gale, R.P., Lazarus, H.M., Marks, D.I., van Rood, J.J., Scaradavou, A. & Horowitz, M.M. (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. New England Journal of Medicine, 351, 2265-2275.
52. Lee, K.H., Lee, J.H., Choi, S.J., Seol, M., Lee, Y.S., Kim, W.K., Lee, J.S., Seo, E.J., Jang, S., Park, C.J. & Chi, H.S. (2005) Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia, 19, 1509-1516.
53. Marks, D.I., Forman, S.J., Blume, K.G., Perez, W.S., Weisdorf, D.J., Keating, A., Gale, R.P., Cairo, M.S., Copelan, E.A., Horan, J.T., Lazarus, H.M., Litzow, M.R., McCarthy, P.L., Schultz, K.R., Smith, D.D., Trigg, M.E., Zhang, M.J. & Horowitz, M.M. (2006) A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biology of Blood and Marrow Transplantation, 12, 438-453.
54. Martino, R., Giralt, S., Caballero, M.D., Mackinnon, S., Corradini, P., Fernandez-Aviles, F., San Miguel, J. & Sierra, J. (2003) Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study. Haematologica, 88, 555-560.
55. McNeer, J.L. & Raetz, E.A. (2012) Acute lymphoblastic leukemia in young adults: which treatment? Current Opinion in Oncology, 4, 487-494.
56. Mizuta, S., Matsuo, K., Yagasaki, F., Yujiri, T., Hatta, Y., Kimura, Y., Ueda, Y., Kanamori, H., Usui, N., Akiyama, H., Miyazaki, Y., Ohtake, S., Atsuta, Y., Sakamaki, H., Kawa, K., Morishima, Y., Ohnishi, K., Naoe, T. & Ohno, R. (2011) Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia. Leukemia, 25, 41-47.
57. Moorman, A.V., Harrison, C.J., Buck, G.A., Richards, S.M., Secker-Walker, L.M., Martineau, M., Vance, G.H., Cherry, A.M., Higgins, R.R., Fielding, A.K., Foroni, L., Paietta, E., Tallman, M.S., Litzow, M.R., Wiernik, P.H., Rowe, J.M., Goldstone, A.H. & Dewald, G.W. (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood, 109, 3189-3197.
58. Mullighan, C.G., Goorha, S., Radtke, I., Miller, C.B., Coustan-Smith, E., Dalton, J.D., Girtman, K., Mathew, S., Ma, J., Pounds, S.B., Su, X., Pui, C.H., Relling, M.V., Evans, W.E., Shurtleff, S.A. & Downing, J.R. (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature, 446, 758-764.
59. Mullighan, C.G., Miller, C.B., Radtke, I., Phillips, L.A., Dalton, J., Ma, J., White, D., Hughes, T.P., Le Beau, M.M., Pui, C.H., Relling, M.V., Shurtleff, S.A. & Downing, J.R. (2008) BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature, 453, 110-114.
60. Mullighan, C.G., Su, X., Zhang, J., Radtke, I., Phillips, L.A., Miller, C.B., Ma, J., Liu, W., Cheng, C., Schulman, B.A., Harvey, R.C., Chen, I.M., Clifford, R.J., Carroll, W.L., Reaman, G., Bowman, W.P., Devidas, M., Gerhard, D.S., Yang, W., Relling, M.V., Shurtleff, S.A., Campana, D., Borowitz, M.J., Pui, C.H., Smith, M., Hunger, S.P., Willman, C.L. & Downing, J.R. (2009a) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. New England Journal of Medicine, 360, 470-480.
61. Mullighan, C.G., Zhang, J., Harvey, R.C., Collins-Underwood, J.R., Schulman, B.A., Phillips, L.A., Tasian, S.K., Loh, M.L., Su, X., Liu, W., Devidas, M., Atlas, S.R., Chen, I.M., Clifford, R.J., Gerhard, D.S., Carroll, W.L., Reaman, G.H., Smith, M., Downing, J.R., Hunger, S.P. & Willman, C.L. (2009b) JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 106, 9414-9418.
62. Nachman, J.B., Heerema, N.A., Sather, H., Camitta, B., Forestier, E., Harrison, C.J., Dastugue, N., Schrappe, M., Pui, C.H., Basso, G., Silverman, L.B. & Janka-Schaub, G.E. (2007) Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood, 110, 1112-1115.
63. Nachman, J.B., La, M.K., Hunger, S.P., Heerema, N.A., Gaynon, P.S., Hastings, C., Mattano, L.A. Jr, Sather, H., Devidas, M., Freyer, D.R., Steinherz, P.G. & Seibel, N.L. (2009) Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group. Journal of Clinical Oncology, 27, 5189-5194.
64. National Comprehensive Cancer Network. (2012) NCCN Clinical Practice Guidelines in Oncology for Acute Lymphoblastic Leukemia Version 2.2012. NCCN.org.
65. Nishiwaki, S., Inamoto, Y., Sakamaki, H., Kurokawa, M., Iida, H., Ogawa, H., Fukuda, T., Ozawa, Y., Kobayashi, N., Kasai, M., Mori, T., Iwato, K., Yoshida, T., Onizuka, M., Kawa, K., Morishima, Y., Suzuki, R., Atsuta, Y. & Miyamura, K. (2010) Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission. Blood, 116, 4368-4375.
66. Pui, C.H., Carroll, W.L., Meshinchi, S. & Arceci, R.J. (2011) Biology, risk stratification, and therapy of pediatric acute leukemias: an update. Journal of Clinical Oncology, 29, 551-565.
67. Pulsipher, M.A., Bader, P., Klingebiel, T. & Cooper, L.J. (2009) Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse. Biology of Blood and Marrow Transplantation, 15, 62-71.
68. Pulte, D., Gondos, A. & Brenner, H. (2009) Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood, 113, 1408-1411.
69. Radhakrishnan, K., Ricci, A.M., Geyer, M.B., Harrison, L., Duffy, D., Ozkaynak, M., Satwani, P., Cheerva, A.C., Talano, J., Moore, T.B., Gillio, A.P., Baxter-Lowe, L.A. & Cairo, M.S. (2012) Low day 100 transplant-related mortality (TRM) following clofarabine (CLO) in combination with cytarabine and total body irradiation (TBI), myeloablative conditioning (MAC) and allogeneic stem cell transplantation (AlloSCT) in children, adolescents and young adults (CAYA) with poor-risk acute leukemia. Biology of Blood and Marrow Transplantation, 18, S290.
70. Raff, T., Gokbuget, N., Luschen, S., Reutzel, R., Ritgen, M., Irmer, S., Bottcher, S., Horst, H.A., Kneba, M., Hoelzer, D. & Bruggemann, M. (2007) Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials. Blood, 109, 910-915.
71. Ram, R., Storb, R., Sandmaier, B.M., Maloney, D.G., Woolfrey, A., Flowers, M.E., Maris, M.B., Laport, G.G., Chauncey, T.R., Lange, T., Langston, A.A., Storer, B. & Georges, G.E. (2011) Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia. Haematologica, 96, 1113-1120.
72. Ribera, J.M., Oriol, A., Gonzalez, M., Vidriales, B., Brunet, S., Esteve, J., Del Potro, E., Rivas, C., Moreno, M.J., Tormo, M., Martin-Reina, V., Sarra, J., Parody, R., de Oteyza, J.P., Bureo, E. & Bernal, M.T. (2010) Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial. Haematologica, 95, 87-95.
73. Rocha, V., Cornish, J., Sievers, E.L., Filipovich, A., Locatelli, F., Peters, C., Remberger, M., Michel, G., Arcese, W., Dallorso, S., Tiedemann, K., Busca, A., Chan, K.W., Kato, S., Ortega, J., Vowels, M., Zander, A., Souillet, G., Oakill, A., Woolfrey, A., Pay, A.L., Green, A., Garnier, F., Ionescu, I., Wernet, P., Sirchia, G., Rubinstein, P., Chevret, S. & Gluckman, E. (2001) Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood, 97, 2962-2971.
74. Rocha, V., Labopin, M., Sanz, G., Arcese, W., Schwerdtfeger, R., Bosi, A., Jacobsen, N., Ruutu, T., de Lima, M., Finke, J., Frassoni, F. & Gluckman, E. (2004) Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. New England Journal of Medicine, 351, 2276-2285.
75. Rowe, J.M. (2010) Prognostic factors in adult acute lymphoblastic leukaemia. British Journal of Haematology, 150, 389-405.
76. Saarinen, U.M., Mellander, L., Nysom, K., Ringden, O., Schroeder, H., Glomstein, A. & Gustafsson, G. (1996) Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO). Bone Marrow Transplantation, 17, 357-363.
77. Satwani, P., Sather, H., Ozkaynak, F., Heerema, N.A., Schultz, K.R., Sanders, J., Kersey, J., Davenport, V., Trigg, M. & Cairo, M.S. (2007) Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: a children's oncology group study report. Biology of Blood and Marrow Transplantation, 13, 218-227.
78. Schrappe, M., Hunger, S.P., Pui, C.H., Saha, V., Gaynon, P.S., Baruchel, A., Conter, V., Otten, J., Ohara, A., Versluys, A.B., Escherich, G., Heyman, M., Silverman, L.B., Horibe, K., Mann, G., Camitta, B.M., Harbott, J., Riehm, H., Richards, S., Devidas, M. & Zimmermann, M. (2012) Outcomes after induction failure in childhood acute lymphoblastic leukemia. New England Journal of Medicine, 366, 1371-1381.
79. Schrauder, A., Reiter, A., Gadner, H., Niethammer, D., Klingebiel, T., Kremens, B., Peters, C., Ebell, W., Zimmermann, M., Niggli, F., Ludwig, W.D., Riehm, H., Welte, K. & Schrappe, M. (2006) Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. Journal of Clinical Oncology, 24, 5742-5749.
80. Schultz, K.R., Bowman, W.P., Aledo, A., Slayton, W.B., Sather, H., Devidas, M., Wang, C., Davies, S.M., Gaynon, P.S., Trigg, M., Rutledge, R., Burden, L., Jorstad, D., Carroll, A., Heerema, N.A., Winick, N., Borowitz, M.J., Hunger, S.P., Carroll, W.L. & Camitta, B. (2009) Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. Journal of Clinical Oncology, 27, 5175-5181.
81. Sebban, C., Lepage, E., Vernant, J.P., Gluckman, E., Attal, M., Reiffers, J., Sutton, L., Racadot, E., Michallet, M. & Maraninchi, D. (1994) Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 12, 2580-2587.
82. Seibel, N.L., Steinherz, P.G., Sather, H.N., Nachman, J.B., Delaat, C., Ettinger, L.J., Freyer, D.R., Mattano, L.A. Jr, Hastings, C.A., Rubin, C.M., Bertolone, K., Franklin, J.L., Heerema, N.A., Mitchell, T.L., Pyesmany, A.F., La, M.K., Edens, C. & Gaynon, P.S. (2008) Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood, 111, 2548-2555.
83. Sharathkumar, A., Saunders, E.F., Dror, Y., Grant, R., Greenberg, M., Weitzman, S., Chan, H., Calderwood, S., Freedman, M.H. & Doyle, J. (2004) Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplantation, 33, 39-45.
84. Socie, G., Stone, J.V., Wingard, J.R., Weisdorf, D., Henslee-Downey, P.J., Bredeson, C., Cahn, J.Y., Passweg, J.R., Rowlings, P.A., Schouten, H.C., Kolb, H.J. & Klein, J.P. (1999) Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. New England Journal of Medicine, 341, 14-21.
85. Stein, A.S., Palmer, J.M., O'Donnell, M.R., Kogut, N.M., Spielberger, R.T., Slovak, M.L., Tsai, N.C., Senitzer, D., Snyder, D.S., Thomas, S.H. & Forman, S.J. (2009) Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia. Biology of Blood and Marrow Transplantation, 15, 1407-1414.
86. Stirewalt, D.L., Guthrie, K.A., Beppu, L., Bryant, E.M., Doney, K., Gooley, T., Appelbaum, F.R. & Radich, J.P. (2003) Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation. Biology of Blood and Marrow Transplantation, 9, 206-212.
87. Stock, W., La, M., Sanford, B., Bloomfield, C.D., Vardiman, J.W., Gaynon, P., Larson, R.A. & Nachman, J. (2008) What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood, 112, 1646-1654.
88. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon, France.
89. Tang, W., Wang, L., Zhao, W.L., Chen, Y.B., Shen, Z.X. & Hu, J. (2011) Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia. Biology of Blood and Marrow Transplantation, 17, 1555-1561.
90. Thomas, E., Storb, R., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P.E., Lerner, K.G., Glucksberg, H. & Buckner, C.D. (1975a) Bone-marrow transplantation (first of two parts). New England Journal of Medicine, 292, 832-843.
91. Thomas, E.D., Storb, R., Clift, R.A., Fefer, A., Johnson, L., Neiman, P.E., Lerner, K.G., Glucksberg, H. & Buckner, C.D. (1975b) Bone-marrow transplantation (second of two parts). New England Journal of Medicine, 292, 895-902.
92. Thomas, X., Boiron, J.M., Huguet, F., Dombret, H., Bradstock, K., Vey, N., Kovacsovics, T., Delannoy, A., Fegueux, N., Fenaux, P., Stamatoullas, A., Vernant, J.P., Tournilhac, O., Buzyn, A., Reman, O., Charrin, C., Boucheix, C., Gabert, J., Lheritier, V. & Fiere, D. (2004) Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. Journal of Clinical Oncology, 22, 4075-4086.
93. Thomas, D.A., O'Brien, S., Jorgensen, J.L., Cortes, J., Faderl, S., Garcia-Manero, G., Verstovsek, S., Koller, C., Pierce, S., Huh, Y., Wierda, W., Keating, M.J. & Kantarjian, H.M. (2009) Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia. Blood, 113, 6330-6337.
94. Tomblyn, M.B., Arora, M., Baker, K.S., Blazar, B.R., Brunstein, C.G., Burns, L.J., DeFor, T.E., Dusenbery, K.E., Kaufman, D.S., Kersey, J.H., MacMillan, M.L., McGlave, P.B., Miller, J.S., Orchard, P.J., Slungaard, A., Tomblyn, M.R., Vercellotti, G.M., Verneris, M.R., Wagner, J.E. & Weisdorf, D.J. (2009) Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome. Journal of Clinical Oncology, 27, 3634-3641.
95. Van der Velden, V.H., Corral, L., Valsecchi, M.G., Jansen, M.W., De Lorenzo, P., Cazzaniga, G., Panzer-Grumayer, E.R., Schrappe, M., Schrauder, A., Meyer, C., Marschalek, R., Nigro, L.L., Metzler, M., Basso, G., Mann, G., Den Boer, M.L., Biondi, A., Pieters, R. & Van Dongen, J.J. (2009) Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol. Leukemia, 23, 1073-1079.
96. Vidriales, M.B., Perez, J.J., Lopez-Berges, M.C., Gutierrez, N., Ciudad, J., Lucio, P., Vazquez, L., Garcia-Sanz, R., del Canizo, M.C., Fernandez-Calvo, J., Ramos, F., Rodriguez, M.J., Calmuntia, M.J., Porwith, A., Orfao, A. & San-Miguel, J.F. (2003) Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value. Blood, 101, 4695-4700.
97. Warren, E.H., Fujii, N., Akatsuka, Y., Chaney, C.N., Mito, J.K., Loeb, K.R., Gooley, T.A., Brown, M.L., Koo, K.K., Rosinski, K.V., Ogawa, S., Matsubara, A., Appelbaum, F.R. & Riddell, S.R. (2010) Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens. Blood, 115, 3869-3878.
98. Wheeler, K.A., Richards, S.M., Bailey, C.C., Gibson, B., Hann, I.M., Hill, F.G. & Chessells, J.M. (2000) Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI. Blood, 96, 2412-2418.
99. Yanada, M., Takeuchi, J., Sugiura, I., Akiyama, H., Usui, N., Yagasaki, F., Kobayashi, T., Ueda, Y., Takeuchi, M., Miyawaki, S., Maruta, A., Emi, N., Miyazaki, Y., Ohtake, S., Jinnai, I., Matsuo, K., Naoe, T. & Ohno, R. (2006) High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group. Journal of Clinical Oncology, 24, 460-466.
100. Zecca, M., Pession, A., Messina, C., Bonetti, F., Favre, C., Prete, A., Cesaro, S., Porta, F., Mazzarino, I., Giorgiani, G., Rondelli, R. & Locatelli, F. (1999) Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings. Journal of Clinical Oncology, 17, 1838-1846.
101. Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S.L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., Lu, C., Chen, S.C., Wei, L., Collins-Underwood, J.R., Ma, J., Roberts, K.G., Pounds, S.B., Ulyanov, A., Becksfort, J., Gupta, P., Huether, R., Kriwacki, R.W., Parker, M., McGoldrick, D.J., Zhao, D., Alford, D., Espy, S., Bobba, K.C., Song, G., Pei, D., Cheng, C., Roberts, S., Barbato, M.I., Campana, D., Coustan-Smith, E., Shurtleff, S.A., Raimondi, S.C., Kleppe, M., Cools, J., Shimano, K.A., Hermiston, M.L., Doulatov, S., Eppert, K., Laurenti, E., Notta, F., Dick, J.E., Basso, G., Hunger, S.P., Loh, M.L., Devidas, M., Wood, B., Winter, S., Dunsmore, K.P., Fulton, R.S., Fulton, L.L., Hong, X., Harris, C.C., Dooling, D.J., Ochoa, K., Johnson, K.J., Obenauer, J.C., Evans, W.E., Pui, C.H., Naeve, C.W., Ley, T.J., Mardis, E.R., Wilson, R.K., Downing, J.R. & Mullighan, C.G. (2012) The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature, 481, 157-163.